NORIAN SKELETAL REPAIR SYSTEM (SRS) CANCELLOUS BONE CEMENT

Filler, Bone Void, Non-osteoinduction

FDA Premarket Approval P970010

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Indicated for use as an adjunct for fracture stabilization in the treatment of low impact, unstable, metaphyseal distal radius fractures, in cases where early mobilization (cast for 2 weeks, then removable splint for 2-4 weeks) is indicated. Use of srs alone in highly comminuted fractures is not indicated.

DeviceNORIAN SKELETAL REPAIR SYSTEM (SRS) CANCELLOUS BONE CEMENT
Classification NameFiller, Bone Void, Non-osteoinduction
Generic NameFiller, Bone Void, Non-osteoinduction
ApplicantSYNTHES (USA)
Date Received1997-02-24
Decision Date1998-12-23
Notice Date1999-10-20
PMAP970010
SupplementS
Product CodeMBS
Docket Number99M-4361
Advisory CommitteeOrthopedic
Expedited ReviewNo
Combination Product No
Applicant Address SYNTHES (USA) 1690 Russell Rd. post Office Box 1766 paoli, PA 19301
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P970010Original Filing
S004 2000-06-06 Normal 180 Day Track
S003
S002 2000-03-02 Normal 180 Day Track
S001 1999-02-08 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.